Page last updated: 2024-12-11

ginsenoside rb2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth
FloraRankFlora DefinitionFamilyFamily Definition
PanaxgenusAn araliaceous genus of plants that contains a number of pharmacologically active agents used as stimulants, sedatives, and tonics, especially in traditional medicine. Sometimes confused with Siberian ginseng (ELEUTHEROCOCCUS).[MeSH]AraliaceaeThe ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).[MeSH]
Panax ginsengspecies[no description available]AraliaceaeThe ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).[MeSH]

Cross-References

ID SourceID
PubMed CID6917976
CHEMBL ID449303
CHEBI ID77152
MeSH IDM0138411

Synonyms (38)

Synonym
ginsenoside c
einecs 234-251-4
nsc 308878
gingenoside c
20-((6-o-alpha-l-arabinopyranosyl-beta-d-glucopyranosyl)oxy)-12beta-hydroxydammar-24-en-3beta-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
beta-d-glucopyranoside, (3-beta,12-beta)-20-((6-o-alpha-l-arabinopyranosyl-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-
ginsenoside rb2 ,
11021-13-9
nsc-308878
DB06748
CHEMBL449303
chebi:77152 ,
S9079
unii-n219o0l31c
n219o0l31c ,
ginsenoside rb2 (constituent of american ginseng, asian ginseng, and tienchi ginseng) [dsc]
.beta.-d-glucopyranoside, (3.beta.,12.beta.)-20-((6-o-.alpha.-l-arabinopyranosyl-.beta.-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-.beta.-d-glucopyranosyl-
CS-3830
(3beta,12beta)-20-{[6-o-(alpha-l-arabinopyranosyl)-beta-d-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
(20s)-ginsenoside rb2
20-[alpha-l-arabinopyranosyl-(1->2)-beta-d glucopyranosyloxy]-3beta-[beta-d-glucopyranosyl-(1->2)-beta-d glucopyranosyloxy]dammar-24-en-12beta-ol
AC-34662
HY-N0040
mfcd00221755
ginsenoside rb2, analytical standard
ginsenoside-rb2
NCGC00485981-01
AKOS037514668
Q27891169
CCG-270635
AS-56619
ginsenosiderb2
bdbm50450908
GLXC-13018
20-(alpha-l-arabinopyranosyl-(1->2)-beta-d glucopyranosyloxy)-3beta-(beta-d-glucopyranosyl-(1->2)-beta-d glucopyranosyloxy)dammar-24-en-12beta-ol
ginsenoside rb2 (constituent of american ginseng, asian ginseng, and tienchi ginseng)
(3beta,12beta)-20-((6-o-(alpha-l-arabinopyranosyl)-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
beta-d-glucopyranoside, (3beta,12beta)-20-((6-o-alpha-l-arabinopyranosyl-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The value of Rb(1) is higher than that of Rb(2) or Rb(3), indicating that ginsenosides with hexose and hydroxyl groups (Rb(1)) could present better pharmacokinetic behaviors than those with pentose groups in the same glycosylation site by oral administration."( Determination of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: Application in a pharmacokinetic study.
Liu, M; Liu, Z; Su, C; Su, W; Tang, L; Yang, C; Zhao, J, 2012
)
0.38
" The validated method was successfully applied to pharmacokinetic and bioavailability studies of ginsenoside Rb2 in rat plasma."( Pharmacokinetic and metabolism study of ginsenoside Rb2 in rat by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Ha, L; Li, X; Wang, W; Yang, E; Zheng, W, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" All three ginsenosides had poor oral bioavailability (0."( Determination of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: Application in a pharmacokinetic study.
Liu, M; Liu, Z; Su, C; Su, W; Tang, L; Yang, C; Zhao, J, 2012
)
0.38
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" The validated method was successfully applied to pharmacokinetic and bioavailability studies of ginsenoside Rb2 in rat plasma."( Pharmacokinetic and metabolism study of ginsenoside Rb2 in rat by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Ha, L; Li, X; Wang, W; Yang, E; Zheng, W, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" In the present study, we found that dose-response Rb2 inhibited high dosage of dexamethasone (Dex)-induced apoptosis in primary murine BMMSCs."( Ginsenoside-Rb2 inhibits dexamethasone-induced apoptosis through promotion of GPR120 induction in bone marrow-derived mesenchymal stem cells.
Gao, B; Guo, YS; Han, YH; Huang, Q; Jie, Q; Liu, J; Luo, ZJ; Sun, Z; Wang, L; Wei, BY; Yang, L; Zhang, HY, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antiviral agentA substance that destroys or inhibits replication of viruses.
hypoglycemic agentA drug which lowers the blood glucose level.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
12beta-hydroxy steroid
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
disaccharide derivativeA carbohydrate derivative that is formally obtained from a disaccharide.
ginsenosideTriterpenoid saponins with a dammarane-like skeleton originally isolated from ginseng (Panax) species. Use of the term has been extended to include semi-synthetic derivatives.
tetracyclic triterpenoidAny triterpenoid consisting of a tetracyclic skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)EC50 (µMol)0.01680.01681.24885.9000AID1364697
5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)EC50 (µMol)0.01680.01681.34635.9000AID1364697
5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)EC50 (µMol)0.01680.01681.24885.9000AID1364697
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (45)

Processvia Protein(s)Taxonomy
regulation of glycolytic process5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
protein phosphorylation5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
fatty acid biosynthetic process5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
signal transduction5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
spermatogenesis5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
positive regulation of gene expression5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
cellular response to nutrient levels5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
positive regulation of protein kinase activity5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
import into nucleus5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
regulation of catalytic activity5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
lipid droplet disassembly5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
chromatin remodeling5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein phosphorylation5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
fatty acid biosynthetic process5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cholesterol biosynthetic process5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
autophagy5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
signal transduction5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
lipid biosynthetic process5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
positive regulation of autophagy5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
negative regulation of gene expression5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
response to muscle activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
Wnt signaling pathway5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
positive regulation of macroautophagy5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
regulation of macroautophagy5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cellular response to nutrient levels5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
negative regulation of TOR signaling5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cellular response to oxidative stress5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cellular response to glucose starvation5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
glucose homeostasis5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
regulation of circadian rhythm5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
negative regulation of apoptotic process5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
positive regulation of glycolytic process5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
rhythmic process5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
fatty acid homeostasis5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
regulation of stress granule assembly5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
regulation of microtubule cytoskeleton organization5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cellular response to calcium ion5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cellular response to glucose stimulus5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cellular response to prostaglandin E stimulus5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cellular response to xenobiotic stimulus5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
energy homeostasis5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
positive regulation of protein localization5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
negative regulation of hepatocyte apoptotic process5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
negative regulation of TORC1 signaling5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
negative regulation of tubulin deacetylation5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein localization to lipid droplet5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
positive regulation of peptidyl-lysine acetylation5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein phosphorylation5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
fatty acid biosynthetic process5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
positive regulation of gene expression5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
cellular response to nutrient levels5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
nail development5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
positive regulation of cold-induced thermogenesis5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
signal transduction5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
protein kinase activity5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
cAMP-dependent protein kinase activity5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
protein binding5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
ATP binding5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
cAMP-dependent protein kinase regulator activity5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
AMP binding5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
protein kinase regulator activity5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
protein kinase binding5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
ADP binding5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
chromatin binding5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein kinase activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein serine/threonine kinase activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
AMP-activated protein kinase activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein serine/threonine/tyrosine kinase activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein binding5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
ATP binding5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
metal ion binding5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein serine kinase activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
histone H2BS36 kinase activity5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
protein kinase activity5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
protein binding5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
protein kinase binding5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
nucleus5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
nucleoplasm5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
cytosol5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
membrane5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
nucleotide-activated protein kinase complex5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
nucleus5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
cytoplasm5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)
nucleus5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
nucleoplasm5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
Golgi apparatus5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cytosol5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cytoplasmic stress granule5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
nuclear speck5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
axon5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
dendrite5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
nucleotide-activated protein kinase complex5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
neuronal cell body5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
nucleus5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
cytoplasm5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)
nucleus5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
nucleoplasm5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
cytosol5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
nucleotide-activated protein kinase complex5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
nucleus5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
cytoplasm5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (50)

Assay IDTitleYearJournalArticle
AID336542Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in serum albumin level at 10 mg/day, ip for 3 days measured after 6 days by BCG method (RVb=3.07+/-0.08 g/dl)
AID336540Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as decrease in serum glucose level at 10 mg/day, ip for 3 days measured after 6 days (RVb=401+/-10.7 mg/dl)
AID359487Hepatoprotective activity in mouse hepatocytes assessed protection against D-galactosamine/TNFalpha-induced cell death at 50 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID336539Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as decrease in incorporation of [14C]leucine into per mg serum protein at 10 mg/day, ip measured after 3 days (RVb=640+/-50 cpm)
AID337256Effect on nitrogen balance in Wistar rat diabetic model assessed as residual fecal nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to non-diabetic control
AID359489Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death at 100 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID1172639Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID337258Effect on nitrogen balance in Wistar rat diabetic model assessed as absorbed nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to non-diabetic control
AID359484Hepatoprotective activity in mouse hepatocytes assessed protection against D-galactosamine/TNFalpha-induced cell death at 200 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID359488Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death dosed administered before 30 mins of TNFalpha challenge measured after 18 hrs2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID336548Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine in to hepatic nuclear fraction at 10 mg/day, ip measured per mg protein after 3 days (RVb=272+/-8 cpm)
AID336543Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in serum albumin level at 10 mg/day, ip for 3 days measured after 3 days by BCG method (RVb=3.24+/-0.11 g/dl)
AID359493Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death at 50 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID359683Hepatoprotective activity in mouse hepatocytes assessed protection against D-galactosamine/TNFalpha-induced cell death at 100 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID1364697Activation of recombinant AMPKalpha2beta1gamma1 (unknown origin) expressed in Escherichia coli BL21 in presence of CaMKKbeta (unknown origin) incubated for 45 mins in presence of substrate-1 peptide and ATP by HTRF assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Malonylginsenosides with Potential Antidiabetic Activities from the Flower Buds of Panax ginseng.
AID336541Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as decrease in serum glucose level at 10 mg/day, ip for 3 days measured after 3 days (RVb=396+/-18.7 mg/dl)
AID359494Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in mouse hepatocytes assessed cell survival rate at 100 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs by MTT assay2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID359682Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in mouse hepatocytes assessed cell survival rate at 50 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs by MTT assay2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID337255Effect on nitrogen balance in Wistar rat diabetic model assessed as residual urinary nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to diabetic control
AID337261Effect on nitrogen balance in Wistar rat diabetic model assessed as retained nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to diabetic control
AID336537Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine into hepatic soluble fraction at 10 mg/day, ip measured per mg protein after 6 days (RVb=227+/-8 cpm)
AID336549Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine into hepatic homogenate at 10 mg/day, ip measured per mg protein after 6 days (RVb=372+/-3 cpm)
AID336544Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in serum protein level at 10 mg/day, ip for 3 days measured after 6 days by biuret method (RVb=4.86+/-0.30 g/dl)
AID336538Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as decrease in incorporation of [14C]leucine into per mg of serum protein at 10 mg/day, ip measured after 6 days (RVb=612+/-40 cpm)
AID359495Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in mouse hepatocytes assessed cell survival rate at 200 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs by MTT assay2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID336550Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine into hepatic homogenate at 10 mg/day, ip measured per mg protein after 3 days (RVb=401+/-16 cpm)
AID337257Effect on nitrogen balance in Wistar rat diabetic model assessed as residual fecal nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to diabetic control
AID336551Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in serum protein level at 10 mg/day, ip for 6 days by biuret method
AID336533Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine into hepatic microsomal fraction at 10 mg/day, ip measured per mg protein after 6 days (RVb=499+/-57 cpm)
AID334335Induction of morphological transformation of rat ASK cells into astrocytes at 100 ug/ml after 1 hr by light microscopy
AID336534Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine into hepatic metabolic fraction at 10 mg/day, ip measured per mg protein after 6 days (RVb=357+/-14 cpm)
AID336545Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in serum protein level at 10 mg/day, ip for 3 days measured after 3 days by biuret method (RVb=5.06+/-0.18 g/dl)
AID336546Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine in to hepatic metabolic fraction at 10 mg/day, ip measured per mg protein after 3 days (RVb=377+/-10 cpm)
AID337259Effect on nitrogen balance in Wistar rat diabetic model assessed as absorbed nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to diabetic control
AID337260Effect on nitrogen balance in Wistar rat diabetic model assessed as retained nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to non-diabetic control
AID336536Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine into hepatic soluble fraction at 10 mg/day, ip measured per mg protein after 3 days (RVb=265+/-8 cpm)
AID1172640Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID359490Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death at 200 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs2001Journal of natural products, Apr, Volume: 64, Issue:4
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.
AID336547Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine in to hepatic nuclear fraction at 10 mg/day, ip measured per mg protein after 6 days (RVb=273+/-8 cpm)
AID1364696Induction of glucose consumption in differentiated rat L6 cells at 20 uM incubated for 12 hrs in presence of 0.5% bovine serum albumin and low-glucose by glucose oxidase method2017Journal of natural products, 04-28, Volume: 80, Issue:4
Malonylginsenosides with Potential Antidiabetic Activities from the Flower Buds of Panax ginseng.
AID1317164Activation of recombinant human SIRT1 using TPE-GK(Ac)YDD as substrate at 1 to 50 uM by fluorescence assay relative to control2016European journal of medicinal chemistry, Aug-25, Volume: 119How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
AID337254Effect on nitrogen balance in Wistar rat diabetic model assessed as residual urinary nitrogen at 10 mg/day, ip for 6 days measured 6 hrs after last dose relative to non-diabetic control
AID1364695Induction of glucose consumption in differentiated rat L6 cells at 10 uM incubated for 12 hrs in presence of 0.5% bovine serum albumin and low-glucose by glucose oxidase method2017Journal of natural products, 04-28, Volume: 80, Issue:4
Malonylginsenosides with Potential Antidiabetic Activities from the Flower Buds of Panax ginseng.
AID336535Antidiabetic activity against streptozotocin-induced diabetic Wistar rat assessed as increase in incorporation of [14C]leucine into hepatic microsomal fraction at 10 mg/day, ip measured per mg protein after 3 days (RVb=555+/-33 cpm)
AID1364698Activation of recombinant AMPKalpha2beta1gamma1 (unknown origin) expressed in Escherichia coli BL21 in presence of CaMKKbeta (unknown origin) incubated for 45 mins in presence of substrate-1 peptide and ATP by HTRF assay relative to untreated control2017Journal of natural products, 04-28, Volume: 80, Issue:4
Malonylginsenosides with Potential Antidiabetic Activities from the Flower Buds of Panax ginseng.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (85)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (3.53)18.7374
1990's16 (18.82)18.2507
2000's21 (24.71)29.6817
2010's32 (37.65)24.3611
2020's13 (15.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.27%)5.53%
Reviews2 (2.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other84 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]